20 June 2013
Keywords: Hikma, Unimark Remedies, Minority stake, Cardiovasculars, Anti-asthma, Anti-infectives
Article | 18 April 2011
Jordan-headquartered generic drugmaker Hikma Pharmaceuticals (LSE: HIK) revealed on Friday that it has agreed to acquire a minority interest - ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.